Fritextsökning
Innehållstyper
-
Samarbetsdags för Big Pharma
Patientkontakt via sociala medier, mobilstödd övervakning av dosering eller datastödd läkemedelsutveckling. Framtidens big pharma-bolag måste vidga vyerna och l...
-
RxEye tar in 30 miljoner i nyemission
Satsar på expansion i Norden.
-
Svenskarna på BIO i USA
Ett 25-tal svenska företag deltog på årets BIO i San Francisco. Huvudsyftet var att träffa andra företag och investerare. En annan svensk på plats var Anders Lö...
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
-
Utvecklingen för Astra Zeneca belyser känsligt ekosystem
Allting hänger ihop. Vilket är värt att minnas för dem som nu tar sig an uppgiften att stärka Sverige efter ett kraftigt decimerat Astra Zeneca.
-
Life science in Stockholm
Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Ny produkt hittar antibiotika i mat
Under året kommer MIP Technologies att lansera flera produkter för att upptäcka små doser av bland annat antibiotikaliknande ämnen i mat.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Köpsugna läkemedelsbolag jagar nya projekt
Köpa eller köpas. Efter marknadsgodkännanden och klirr i kassan cirkulerar rykten om uppköp. Men de svenska forskningsbolagen framhåller att de kommer att stå för köpandet.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Brighter till Nasdaq
När börsen öppnades på fredagsmorgonen anslöt ytterligare ett bolag till aktiemarknaden.
-
En femtedel life science-bolag på hetaste listan
Bland de 33 mest lovande teknikbolagen i Sverige finns sju hopp inom life science med.
-
Kritiserad organisation stöps om
Nu sjösätts den nya organisationen Business Sweden som ett resultat av att Invest Sweden och Exportrådet slagits samman.
-
Continuous sampling allows for instantaneous microbial detection
Biovigilant's IMD-A instruments employ an optical technology to continuously sample the air and immediately warn when microbial contamination is detected.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
BREAKING